New hope for rare leukemia: oral drug trial targets tough cases
Disease control
Ongoing
This study is for people with a rare type of leukemia called T-cell large granular lymphocytic leukemia (T-LGLL) that has returned or not improved with standard treatments. The trial tests an oral chemotherapy drug, CC-486 (azacitidine), to find the best dose and see if it can sh…
Phase: PHASE1, PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated May 17, 2026 04:16 UTC